• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Public Health

Conclusions can change following reanalysis of randomized clinical trial data

byPriyanka Vedak
November 30, 2014
in Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. 35% of reanalyzed clinical trials demonstrated conclusions that differed from the conclusions reached by the original article.

2. No statistically significant association was noted between changes in article conclusions following reanalysis and the use of independent versus original study authors.

Evidence Rating Level: 2 (Good)           

Study Rundown: Randomized controlled trials (RCT) are considered the gold standard of medical research. This study aimed to identify those RCTs that underwent reanalysis and to characterize variations in analysis techniques, study authorship, and the effect of this reanalyzed data on trial conclusions. Strengths of this study include the thorough methodology used to identify reanalysis studies. While only 37 reanalyses were ultimately included in this paper, the authors evaluated 2948 studies for appropriateness for inclusion. The results of this study are limited by factors inherent to the journal publication process. As journals may have demonstrated higher interest in the publication of reanalysis studies that disputed original study findings rather than those that confirmed them, the true percentage of clinical trials demonstrating conclusions that differed from the conclusions reached by the original article may in fact be smaller than the percentage identified by this study. Overall, however, this study highlights the paucity of reanalysis studies in the medical literature and reignites the debate surrounding the availability of open access to raw study data.

Click to read the study, published today in JAMA

Click to read the accompanying editorial, published today in JAMA

RELATED REPORTS

FDA-cleared AI devices rarely have patient outcome data

Food and Drug Administration reviews model for predicting drug related liver injury

Relevant Reading: Data: to share or not to share?

In-Depth [systematic review]: This study utilized MEDLINE search terminology to identify 2948 articles reporting reanalysis data. 37 reanalysis were ultimately included and were examined for differences in study characteristics, authorship, statistical analysis methods, and study conclusions. 13 of these studies (35%) demonstrated conclusions different from those reached by the original article. While only 5 reanalyses utilized a panel of authors that was completely different from those individuals involved in the original study, no statistically significant association was noted between changes in article conclusions following reanalysis and the use of independent versus original study authors (Odds Ratio 0.3, Confidence Interval, 0.04-2.11, P=0.32).

More from this author: No mortality benefit with bilateral mastectomy vs breast-conserving surgery, Intermittent vagal nerve block ineffective for weight loss in obesity, Erythropoietin linked with reduced risk of brain injury in preterm infants, Guided patient self-management of blood pressure medications effective, Collaborative model effective in treating teen depression

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: Clinical trials
Previous Post

Dementia patients frequently on medications with minimal benefit

Next Post

Paradoxical response to beta-2 agonists found in African-Americans, linked to morbidity

RelatedReports

A cargo ship transporting pharmaceutical containers across water, symbolizing challenges in the medicine supply chain.
Public Health

FDA-cleared AI devices rarely have patient outcome data

September 10, 2026
Medicine safety collage: a brass balance scale with a two-tone capsule on one pan and a blue paper shield on the other
All Specialties

Food and Drug Administration reviews model for predicting drug related liver injury

September 4, 2026
Metformin collage: a large scored white tablet, a sprig of goat's rue, an hourglass and a coiled tape measure
Chronic Disease

Metformin remains a leading candidate for pharmacologic longevity intervention

May 19, 2026
Oncology

Spiritual health may be high among cancer patients in drug clinical trials

November 7, 2023
Next Post

Paradoxical response to beta-2 agonists found in African-Americans, linked to morbidity

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis
  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.